CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
The new online Learning Center with new content can still be found under the “Training” folder on ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...